Involvement of prostaglandins in cachexia induced by T-cell leukemia in the rat

Metabolism: Clinical and Experimental

Volumn 46, Issue 4, 1997, Pages 359-365

  Roe, S Y ^a   Cooper, A L ^a   Morris, I D ^a   Rothwell, N J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLURBIPROFEN; INDOMETACIN; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CACHEXIA; CONTROLLED STUDY; ENERGY EXPENDITURE; EPIDIDYMIS FAT; FOOD INTAKE; HYPERMETABOLISM; HYPOPHAGIA; MALE; METABOLIC RATE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT; T CELL LEUKEMIA; WEIGHT REDUCTION;

EID: 0030969380     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90047-0     Document Type: Article

References (35)

1. Norton JA, Peacock JL, Morrison SD: Cancer cachexia. Crit Rev Oncol Hematol 7:289-327, 1987
2. DeWys WD, Begg C, Lavin PT, et al: Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 69:491-497, 1980
3. Lundholm K, Edström S, Karlberg I, et al: Relationship of food intake, body composition, and tumor growth to host metabolism in non-growing mice with sarcoma. Cancer Res 40:2516-2522, 1980
4. Balducci L, Hardy C: Cancer and nutrition: A review. Compr Ther 13:60-69, 1987
5. Arbeit JM, Lees DE, Corsey R, et al: Resting energy expenditure in controls and cancer patients with localized and diffuse disease. Ann Surg 199:292-298, 1984
6. Plumb JA, Fearon KCH, Carter KB: Energy expenditure and protein synthesis rates in an animal model of cancer cachexia. Clin Nutr 10:23-29, 1991
7. Langstein HN, Norton JA: Mechanisms of cancer cachexia. Hematol Oncol Clin North Am 5:103-123, 1991
8. Tanaka Y, Tanaka T, Ishitsuka H: Antitumour activity of indomethacin in mice bearing advanced colon 26 carcinoma compared with those of early transplants. Cancer Res 49:5935-5939, 1989
9. Sandström R, Gelin J, Lundholm K: The effect of indomethacin on food and water intake, motor activity and survival in tumour-bearing rats. Eur J Cancer 26:811-814, 1990
10. Gelin J, Andersson C, Lundholm K: Effects of indomethacin, cytokines and cyclosporin A on tumor growth and the subsequent development of cancer cachexia. Cancer Res 51:880-885, 1991
11. Hudson EA, Tisdale MJ: Comparison of the effectiveness of eicosapentaenoic acid administered as either the free acid or ethyl ester as an anticachectic and antitumour agent. Prosteglandins Leukot Essent Fatty Acids 51:141-145, 1994
12. Lundholm K, Gelin J, Hyltander A, et al: Anti-inflammatory treatment may prolong survival in undernourished patients with meta-static solid tumours. Cancer Res 54:5602-5606, 1994
13. Rothwell NJ: Eicosanoids, thermogenesis and thermoregulation. Prostaglandins Leukot Essent Fatty Acids 46:1-7, 1992
14. Kunkel SL, Chensue SW, Phan SH: Prostaglandins as endogenous mediators of interleukin-1 production. J Immunol 136:186-192, 1986
15. Tisdale MJ: Role of prostaglandins in metastatic dissemination of cancer. Exp Cell Biol 51:250-256, 1983
16. Dascombe MJ, Milton AS: Study on the possible entry of bacterial endotoxin and PGE2 into the central nervous system from the blood. Br J Pharmacol 66:565-572, 1979
17. Murphy S, Pearce B: Eicosanoids in the CNS: Sources and effects. Prostaglandins Leukot Essent Fatty Acids 31:165-170, 1988
18. Rothwell NJ: Central activation of thermogenesis by prostaglandins: Dependence on CRF. Horm Metab Res 22:616-618, 1990
19. Scaramuzi OE, Baue CA, Mayer J: Prostaglandins and food intake of rats. Experientia 27:257, 1971
20. Fischer BD, Barcos VE, Reid DC: Effect of systemic inhibition of prostaglandin synthesis on muscle protein after trauma in the rat. Can J Physiol Pharmacol 69:831-836, 1991
21. Carlson LA: Metabolic and cardiovascular effects in vitro of prostaglandins, in Bergstrom S, Samuelsson B (eds): Prostaglandins; Proceedings of the Second Nobel Symposium, Stockholm. Stockholm, Sweden, Almqvist & Witsell, 1967, p 123
22. Roe S, Cooper AL, Morris ID, et al: Mechanisms of cachexia induced by T-cell leukemia in the rat. Metabolism 45:645-651, 1996
23. Dibley M, Dorsch S, Roser B: T-cell leukaemia in the rat: The pathophysiology. Pathology 7:219-235, 1975
24. Jackson H, Jackson NC, Bock M, et al: Testicular invasion and relapse and meningeal involvement in a rat T-cell leukaemia. Br J Cancer 50:617-624, 1984
25. Stock MJ: An automatic closed circuit calorimeter for short term measurements for small animals. J Appl Physiol 39:849-850, 1975
26. Cooper AL, Rothwell NJ: Mechanisms of early and late hypermetabolism and fever after localised tissue injury in rats. Am J Physiol 261:E698-E705, 1991
27. Popp MB, Brennan MF, Morrison SD: Resting and activity energy expenditure during total parental nutrition in rats with methylcholanthrene-induced sarcoma. Cancer 49:1212-1220, 1982
28. Morrison SD: Partition of energy expenditure between host and tumour. Cancer Res 31:98-107, 1971
29. Dempsey DT, Feurer ID, Knox LS. et al: Energy expenditure in malnourished gastrointestinal cancer patients. Cancer 53:1265-1273, 1984
30. Hytlander A, Körner U, Lundholm KG: Evaluation of mechanisms behind elevated energy expenditure in cancer patients with solid tumours. Eur J Clin Invest 23:46-52, 1993
31. Watanabe T, Moriomoto A, Murakami N: ACTH response in rats induced during biphasic fever induced by interleukin-1. Am J Physiol 261:R1104-R1108, 1991
32. McCarthy DO, Daun JM: The effects of cyclo-oxygenase inhibitors on tumor-induced anorexia in rats. Cancer 71:486-492, 1993
33. Nozu K: Flurbiprofen: A highly potent inhibitor of prostaglandin synthesis. Biochem Biophys Acta 529:493-496, 1978
34. Favalli C, Garaci E, Etheredge E, et al: Influence of PGE on the immune response in melanoma-bearing mice. J Immunol 125:897-902, 1980
35. Feldman JM, Hilf R: Failure of indomethacin to inhibit growth of R3230AC mammary tumor in rats. J Natl Cancer Inst 75:751-756, 1985